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SUMMARY
In eukaryotes, cellular respiration is driven by mitochondrial cytochrome c oxidase (CcO), an 
enzyme complex that requires copper cofactors for its catalytic activity. Insertion of copper into its 
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catalytically active subunits, including COX2, is a complex process that requires 
metallochaperones and redox proteins including SCO1, SCO2, and COA6, a recently discovered 
protein whose molecular function is unknown. To uncover the molecular mechanism by which 
COA6 and SCO proteins mediate copper delivery to COX2, we have solved the solution structure 
of COA6, which reveals a coiled-coil-helix-coiled-coil-helix domain typical of redox-active 
proteins found in the mitochondrial inter-membrane space. Accordingly, we demonstrate that 
COA6 can reduce the copper-coordinating disulfides of its client proteins, SCO1 and COX2, 
allowing for copper binding. Finally, our determination of the interaction surfaces and reduction 
potentials of COA6 and its client proteins provides a mechanism of how metallochaperone and 
disulfide reductase activities are coordinated to deliver copper to CcO.
Graphical Abstract
In Brief
Soma et al. reports the solution structure of cytochrome c oxidase assembly factor COA6 and 
establishes that it functions as a thiol-disulfide oxidoreductase in a relay system that delivers 
copper to COX2, a copper-containing subunit of the mitochondrial cytochrome c oxidase.
INTRODUCTION
Copper (Cu) is a redox-active transition metal that plays essential roles in cellular 
physiology by acting as a catalytic cofactor in numerous enzymatic reactions (Kim et al., 
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2008). One of the most critical Cu-containing enzymes is cytochrome c oxidase (CcO), a 
multimeric heme-Cu oxidase that is integral to the inner mitochondrial membrane and is the 
main site of cellular respiration (Ferguson-Miller and Babcock, 1996). CcO activity and its 
assembly depend on the formation of two Cu centers—CuA and CuB—on the COX2 and 
COX1 subunits, respectively (Tsukihara et al., 1995). These centers provide a molecular 
conduit for the transfer of electrons from reduced cytochrome c to molecular oxygen, the 
terminal step in mitochondrial respiration.
The high chemical reactivity and thiophilic nature of Cu ions present a challenge for its 
transport and insertion into target enzymes. Aqueous Cu ions can drive the production of 
deleterious hydroxyl radicals (Halliwell and Gutteridge, 1984) and can displace other metal 
ions from proteins, impairing their proper function and preventing its own delivery to 
cuproproteins (Foster et al., 2014; Macomber and Imlay, 2009). Moreover, the reduced 
oxidation state of cysteine ligands in cuproproteins, which coordinate Cu via their sulfhydryl 
groups, is necessary for Cu binding (Abriata et al., 2008). Not surprisingly, metallation of 
CcO is a complex process that requires several evolutionarily conserved proteins with 
distinct roles in Cu delivery and insertion (Soto et al., 2012; Timón-Gómez et al., 2018). For 
example, delivery of Cu to the cysteine-bridged binuclear CuA site requires at least four 
proteins– COX17, SCO1, SCO2, and COA6; all of which are either localized to the 
mitochondrial inter-membrane space (IMS) or anchored to the inner mitochondrial 
membrane with their functional domains facing the IMS (Vögtle et al., 2017). These 
proteins are part of a relay system, where Cu ions are sequentially transferred from COX17 
to SCO1 and then to the CuA site of the COX2 subunit (Horng et al., 2004; Banci et al., 
2008; Morgada et al., 2015). Structural and functional analyses of the yeast and human 
COX17 and SCO1 proteins have shown that they both coordinate Cu through their cysteinyl 
residues (Abajian et al., 2004; Abajian and Rosenzweig 2006; Banci et al., 2006, 2008) and 
act as metallochaperones (Banci et al., 2008; Horng et al., 2004; Morgada et al., 2015). 
Human SCO2 acts as a thiol-disulfide oxidoreductase of SCO1 in vivo and COX2 in vitro 
(Leary et al., 2009; Morgada et al., 2015). These findings show that in addition to the 
metallochaperone activity of COX17 and SCO1, a thiol-disulfide oxidoreductase activity is 
essential for inserting Cu into the CuA site.
Recently, we reported that the poorly characterized CcO assembly factor COA6 is a novel 
member of the Cu delivery pathway to CcO (Ghosh et al., 2014). Subsequent biochemical 
and genetic interaction studies showed that COA6 interacts with SCO1, SCO2, and COX2, 
and that it has an overlapping function with SCO2 in the biogenesis of the CuA site (Ghosh 
et al., 2016; Pacheu-Grau et al., 2015; Stroud et al., 2015). Loss of COA6 in many 
organisms results in a severe CcO deficiency, demonstrating its conserved role in this 
pathway (Ghosh et al., 2014). Loss-of-function mutations in COA6 in human mitochondrial 
disease patients result in fatal infantile cardiomyopathies, further highlighting its critical 
requirement in cellular respiration (Baertling et al., 2015; Calvo et al., 2012). Pathogenic 
mutations have also been reported in the COA6-interacting partners SCO1 and SCO2, and 
SCO patients present with similar, early onset clinical syndromes owing to an isolated CcO 
deficiency (Papadopoulou et al., 1999; Stiburek et al., 2009). Although these observations 
emphasize the centrality of this pathway to CcO biogenesis, the precise biochemical 
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function of COA6 and the nature of its interactions with various partners during CuA site 
maturation are still largely unknown.
Here, we address these unknowns by a combination of a nuclear magnetic resonance 
(NMR)-based structural determination and in vitro and in vivo mechanistic biochemistry. We 
show that COA6 adopts a coiled-coil-helix-coiled-coil-helix (CHCH) domain, preferentially 
interacts with SCO1, and exhibits thiol-disulfide oxidoreductase activity both in vitro and in 
vivo, with SCO1 and COX2 being its client proteins. We further demonstrate that COA6 is 
not a Cu-binding protein under physiological conditions and that its enzymatic activity is 
independent of metalation state. Collectively, our data suggest a mechanistic picture in 
which COA6 and SCO2 act as disulfide reductases during the stepwise transfer of Cu from 
Cox17 to the CuA site.
RESULTS
Human COA6 Is a Helical Protein with a CHCH Domain
To uncover the molecular function of COA6, we first solved the solution structure of human 
COA6 isoform 3, hereafter referred to as COA6 (Figure 1A). We chose isoform 3 for our 
structural studies because it encompasses the most well-conserved region of the full-length 
protein and it contains the primary structure that functionally complements yeast coa6Δ cells 
(Ghosh et al., 2016). Human COA6 was expressed as a glutathione S-transferase (GST) 
fusion protein and the GST tag was cleaved with thrombin protease to release free COA6 
(Figure 1B). Subsequent gel-filtration analysis suggests that COA6 exists predominantly as 
an ~18-kDa dimer (Figure 1C). Isotope-enriched COA6 samples were then prepared and the 
structure determined using distance and angle restraints obtained from 2D and 3D 
heteronuclear NMR spectra. The 1H-15N heteronuclear signal quantum correlation (HSQC) 
spectrum of COA6 shows well-dispersed resonances, indicative of a folded protein as well 
as parts lacking stable structure (Figure 1D; PDB: 6NL3). The unstructured nature of N- and 
C-terminal residues is evident from 1H-15N NOE data (Figures S1A–S1C). Sixty-seven out 
of the expected 75 15N backbone amide resonances were detected and approximately 90% of 
all detectable carbon, nitrogen, and hydrogen nuclei were assigned.
To determine if dimerization of COA6 is affected by its concentration, we acquired the 
1H-15N HSQC spectrum of COA6 at varying protein concentrations (Figure S1D). Analysis 
of the relative chemical shift perturbations at the lowest compared to the highest COA6 
concentration (Figure S1E) indicates that the residues in helix 3 of COA6 are likely involved 
in dimerization. Comparable gel-filtration elution profiles in the presence and absence of 
tris(2-carboxyethyl)phosphine (TCEP) argue that the dimerization of COA6 is unaffected by 
a strong reducing agent (Figure S1F). This finding suggests that dimerization is not due to 
inter-disulfide bonding between cysteine residues of each COA6 monomer.
We obtained an ensemble of 20 COA6 structures in excellent agreement with experimental 
restraints (Table S1). This ensemble indicates that the N and C termini of COA6 (residues 1–
8 and 65–79, respectively) are unstructured (Figure 1E). The lowest energy conformer of 
COA6 shows that the compact core, encompassing residues 9–64, is entirely helical and is 
composed of four helices, with the first two, H1 and H2, stabilized by a pair of disulfide 
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bonds (Figure 1F). The CB chemical shifts of each cysteine (C12, 37.566 ppm; C22, 32.450 
ppm; C33, 32.006 ppm; and C44, 45.634 ppm) were interpreted alongside NOESY patterns 
to deduce disulfide pairing (Sharma and Rajarathnam, 2000). Addition of TCEP to purified 
COA6 produced only localized changes in the HSQC spectrum, including splitting of the 
W20 side chain peak (Figures S1G and S1H). Since W20 is proximal to the C22-C33 
disulfide, this phenomenon is likely due to the reduction of this disulfide bond. COA6 
exhibits a CHCH domain reminiscent of many mitochondrial IMS proteins with proposed 
roles in redox chemistry (Banci et al., 2009b). To further determine if the structural features 
of COA6 are conserved in yeast Coa6, we analyzed the 1H-15N HSQC spectrum and 
chemical shift index (CSI) of recombinant yeast Coa6 and found that it is also a helical 
protein (Figures S2A and S2B).
Mapping COA6 Patient Mutations onto the COA6 Structure Uncovers the Structural Basis 
of Pathogenicity
Mutations in COA6 have been reported in two unrelated human mitochondrial disease 
patients: one with compound heterozygous mutations (W59C and E87X) (Calvo et al., 2012) 
and the other with a homozygous missense mutation (W66R) (Baertling et al., 2015). These 
residues are highly conserved, suggesting their essential function (Figure 2A). To understand 
how these mutations affect COA6 function, we mapped the mutated residues onto the COA6 
structure. The truncation mutation (E87X) clearly disrupts the CHCH domain by removing a 
large portion of the protein from helix 2 onward (Figures 2A and 2B). The other two 
mutations, W59C and W66R, are found within the first helix of COA6, where the side 
chains of each tryptophan face the bulk solvent, suggesting that these residues may facilitate 
interactions with their client proteins (Figure 2B).
To further test the effect of these two missense mutations on COA6 function, we introduced 
patient mutations into a human-yeast chimera (hyCOA6) that consists of the bulk of the 
human protein and the N-terminal 24 amino acid residues of yeast Coa6 to facilitate 
mitochondrial targeting (Figure 2A). As expected based on our previous study, the 
respiratory growth of coa6Δ cells was restored by hyCOA6 (Ghosh et al., 2016) but not by 
either of the tryptophan variants, suggesting that these missense mutations disrupt COA6 
function or expression (Figure 2C). To distinguish between these two possibilities, we 
measured the expression of COA6 mutants and found that while hyCOA6W33R and the 
truncated protein hyCOA6E54X are undetectable, hyCOA6W26C is expressed and localizes to 
mitochondria (Figures 2D and 2E). These data suggest that the W26C mutation perturbs 
COA6 function. To further study the effect of these mutations within the context of human 
cells, we overexpressed the wild-type (WT) and mutant alleles of COA6 in control and 
COA6 patient fibroblasts and found that the W66R variant fails to rescue CcO activity 
(Figure 2F). In contrast, expression of the W59C mutant leads to a partial recovery of CcO 
activity and COX2 levels (Figures 2D and 2E), consistent with a previous report (Stroud et 
al., 2015). Curiously, COA6 abundance in patient cells overexpressing the W59C and W66R 
mutants was comparable and at the lower limits of detection (Figure 2G). It seems that in 
most cell types residual levels of the partially functional W59C allele are not sufficient to 
support CcO assembly and mitochondrial respiration because coa6Δ cells expressing the 
W59C variant do not exhibit respiratory growth (Figure 2C) and the human patient with the 
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W59C mutation exhibits a severe CcO deficiency in cardiac tissue (Calvo et al., 2012). 
Taken together, these data strongly suggest that the conserved tryptophans are critical for 
COA6 stability and possibly for their interactions with client proteins.
COA6 Preferentially Interacts with SCO1 over SCO2
Previous studies from yeast and human cell lines have shown that COA6 interacts with 
COX2 and SCO proteins in vivo (Ghosh et al., 2016; Pacheu-Grau et al., 2015; Stroud et al., 
2015). Genetic and physical interaction studies demonstrate that yeast Coa6 interacts with 
both Sco1 and Sco2 (Ghosh et al., 2016). However, studies of human COA6 are less 
conclusive, with one group reporting that COA6 physically interacts only with SCO2 
(Pacheu-Grau et al., 2015) and another group reporting interactions only with SCO1 (Stroud 
et al., 2015).
Given the uncertainty surrounding the relative affinity of COA6 for its interacting partner(s), 
we decided to further investigate COA6 interactions with the SCO proteins by conducting 
competitive binding analysis using size-exclusion chromatography (SEC). First, we 
determined the elution profiles of each protein in isolation. The elution profile for COA6 
shows a right-tailing-effect (Figure 3A), suggesting equilibrium between monomeric and 
dimeric forms (~18 kDa) of the protein. The soluble domains of SCO1 and SCO2 behave as 
monomeric 20- and 17.6-kDa proteins, respectively (Figures 3B and 3C).
We then obtained elution profiles for different mixtures of these proteins. An equimolar 
mixture of COA6 and SCO1 led to the formation of a complex of ~27 kDa, and the absence 
of a peak corresponding to COA6 alone, indicating that all of the COA6 is found within the 
higher molecular weight complex (Figure 3D). Excess SCO1 appears as a shoulder on the 
chromatogram (Figure 3D). Based on the apparent molecular weight of the complex, COA6 
appears to interact with SCO1 as a monomer and with relatively high affinity. Next, we 
analyzed an equimolar mixture of COA6 and SCO2 and observed the formation of higher 
molecular weight complexes, suggesting that SCO2 can also interact with COA6 (Figure 
3E).
To better probe the competitive binding of SCO1 and SCO2 with COA6, a mixture of all 
three proteins was prepared and analyzed by SEC. Three distinct peaks were identified in the 
elution profile (Figure 3F). Through curve fitting, we compared this elution profile with 
traces of each individual protein (Figure 3G) and with traces of the mixtures of two proteins 
(Figure 3H), and found that the high molecular weight peak corresponds to the SCO1:COA6 
complex and the remaining two peaks correspond to SCO1 and SCO2 alone. To confirm the 
constituents of the elution profile, we performed an immunoblot analysis of each eluted 
fraction to detect both SCO proteins and COA6. We found that the majority of COA6 co-
elutes with SCO1 (Figure 3I), strongly suggesting that at least in vitro SCO1 is the dominant 
interacting partner of COA6.
COA6 Uses a Largely Non-polar Interface to Interact with SCO1
To identify the surfaces that facilitate interactions between COA6 and SCO1, we compared 
HSQC spectra of 15N-labeled COA6 obtained in the presence and absence of unlabeled 
SCO1. A comparison of the two spectra identified pronounced chemical shift perturbations 
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in residues 49–55 present in helix 3 and residues 65–69 that form a β-hairpin turn of COA6 
(Figures 4A and 4B). Most of these COA6 residues are non-polar, suggesting hydrophobic 
interactions between COA6 and SCO1. Notably, we did not detect perturbations in the N-
terminal residues of COA6, around the patient mutations corresponding to W20, suggesting 
that these residues are not critical for the interaction with SCO1 (Figures 4A and 4B).
To obtain complementary information about the interaction surface on SCO1, we performed 
the reciprocal experiment where HSQC spectra of 15N-labeled SCO1 were obtained in the 
presence and absence of unlabeled COA6. This led to the identification of a number of non-
polar residues present on the same face of the SCO1 surface (Figures 4C and 4D). 
Interestingly, the surface that SCO1 uses to interact with COA6 is also highly conserved in 
SCO2 (Figure S3A), suggesting that COA6 is capable of interacting with each SCO protein 
via a common surface (Figure S3). Using the chemical shift perturbation data, we generated 
a hypothetical docking model for the SCO1:COA6 complex using High Ambiguity Driven 
protein-protein Docking (HADDOCK) (de Vries et al., 2010). This model shows that the 
Cu-binding cysteines of SCO1 (Cys169 and Cys173) are located in a U-shaped turn region 
that makes direct intermolecular contact with the H3 helix of COA6 (Figure 4E). In 
particular, the indole side chain of W48 from COA6 (highlighted red in Figure 4E) is within 
3Å of the sulfhydryl side chain of Cys173 from SCO1 (Figure 4E). The indole side chain of 
W48 is also located halfway between Cys173 of SCO1 and Cys44 of COA6, suggesting that 
W48 may bridge or otherwise relay electrons from the Cys12/ Cys44 disulfide bridge of 
COA6 to the Cu-binding cysteines of SCO1 (Cys169/Cys173). The COA6 and SCO1 
intermolecular structural interaction is largely composed of hydrophobic residues localized 
to the H3 helix and the C-terminal tail of COA6 (Figure 4E). To test the validity of the 
interaction model, we generated two truncated forms of COA6 by deleting residues 64–79 
(COA6Δ64–79) and residues 72–79 (COA6Δ72–79) from the C terminus. We confirmed that 
both the truncated forms of COA6 are expressed but are not functional, likely due to loss of 
their interaction with SCO1 (Figures 4F and 4G). Superimposition of the known missense 
mutations in SCO1 and SCO2 onto their ribbon diagrams further suggests that at least some 
of the pathogenic variants (e.g., SCO1 P174L, SCO2, and E140K) are close to the mapped 
interacting residues in COA6 (Figures S3B and S3C). Taken together, interaction mapping 
and genetic complementation data suggest that H3 and C-terminal residues of COA6 are 
critical for its interaction with SCO1.
COA6 Function Can Be Bypassed in a Reducing Environment
Although previous work has shown that human COA6 binds Cu with high affinity in vitro 
(Stroud et al., 2015), suggesting a possible metallochaperone function, Cu was not detected 
in the purified COA6 samples that we used for our structural studies. We therefore sought to 
definitively determine the Cu-binding properties of COA6. To do this, we first utilized a 
custom-built online liquid chromatography-inductively coupled plasma mass spectrometry 
(LC-ICP-MS) system, which allows simultaneous detection of Cu and protein in elution 
fractions obtained from SEC. When purified COA6 was applied to this LC-ICP-MS system, 
we detected a major peak at A280 corresponding to the COA6 dimer, although the peak was 
asymmetric and exhibited a right-tailing-effect, suggesting minor contributions from a 
monomeric species (Figure S4A). We did not detect any Cu peaks in the chromatogram, 
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indicating that recombinant COA6 does not bind endogenous Cu from E. coli (Figure S4A). 
When purified COA6 was reconstituted with CuSO4 and reduced glutathione as described 
previously (Stroud et al., 2015), we detected two major A280 peaks corresponding to a dimer 
and a low-intensity higher-molecular-weight species that likely corresponds to an aggregate 
of COA6 and Cu (Figure S4B). Indeed, the Cu peak was detected in the same fractions as 
COA6, with excess Cu found in the high-molecular-weight COA6 aggregates (Figure S4B). 
Thus, upon reconstitution in the presence of reduced glutathione, COA6 can bind Cu; 
however, we suspected that this was not the physiological form of the protein.
To address this issue, we tested whether Cu can bind Coa6 in vivo by analyzing yeast 
mitochondrial fractions. Lysates from anaerobically purified WT and coa6Δ mitochondria 
were subjected to LC-ICPMS to identify Cu-specific peaks using a method we recently 
described (Nguyen et al., 2019). In WT mitochondria, we detected four Cu peaks, including 
one at the void volume and the others associated with masses of circa 30, 20, and 10 kDa 
(Figure 5A). coa6Δ samples exhibited nearly identical Cu peaks in the region associated 
with the same masses (Figure 5B). Notably, none of these Cu peaks corresponds to the 
fractions containing Coa6 (Figures 5C and 5D). The lack of any difference in the Cu peaks 
in the WT and coa6Δ mitochondrial lysates suggests that Coa6 does not bind Cu under 
physiological conditions in yeast cells and is therefore unlikely to act as a Cu 
metallochaperone.
The presence of a CHCH domain in the COA6 structure is consistent with a redox role for 
the protein in CuA site maturation, because the CHCH domain has been proposed to 
represent the minimal oxidoreductase domain, and a number of mitochondrial IMS proteins 
with this domain are indeed redox active (Banci et al., 2009a, 2009b). To begin investigating 
the potential redox role for COA6 in Cu delivery to CcO in vivo, we utilized hypoxic (4% 
O2) conditions (Bihlmaier et al., 2007) to counter the oxidizing environment of the 
mitochondrial IMS (Hu et al., 2008). coa6Δ and other mutants involved in Cu delivery to 
CcO were cultured under normoxic or hypoxic conditions in both fermentable and 
respiratory media. The respiratory growth of coa6Δ was almost fully rescued in hypoxic 
yeast, while that of yeast strains lacking proteins with established Cu metallochaperone 
activity (sco1Δ, cox17Δ, and cox11Δ) was not (Figure 5E). This finding suggests that 
hypoxia cannot replace a metallochaperone function and is likely more specific to rescuing 
the functional deficiency in redox-related proteins (Figure 5E). Consistent with this idea, we 
also observed a partial rescue of coa6Δ yeast that also lacks Sco2, a protein with an 
established disulfide reductase activity in Cu delivery to CcO (Figure 5E). We were unable 
to test the effect of hypoxia on a sco2Δ strain directly, because yeasts lacking Sco2 do not 
have a pronounced respiratory growth-related phenotype (Figure 5E).
The respiratory growth defect of coa6Δ cells has been attributed to a decrease in the levels of 
Cox2, which degrades rapidly when Cu delivery to CcO is impeded (Ghosh et al., 2014; 
Pacheu-Grau et al., 2015). Therefore, to test whether Cu delivery to Cox2 is restored under 
hypoxic conditions, we measured Cox2 abundance in coa6Δ cells and found that it was 
indeed restored to the WT levels (Figure 5F). Moreover, exogenous supplementation of a 
normoxic culture with reduced glutathione (GSH) also partially rescued respiratory growth 
of coa6Δ cells (Figure 5G), further supporting a redox role for Coa6 in the Cu delivery 
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process. Taken together, these results strongly suggest that Coa6 has a redox as opposed to a 
metallochaperone function in Cu delivery to Cox2.
COA6 Acts as a Disulfide Reductase of SCO and COX2 Proteins
Previous work on the biogenesis of the prokaryotic CuA center of heme-Cu oxidases 
established the requirement for both Cu metallochaperones and disulfide reductases (Abriata 
et al., 2008). The presence of a CHCH domain, its redundancy in a hypoxic environment, 
and its overlapping function with SCO2 (Ghosh et al., 2016) all argue that COA6 harbors 
disulfide reductase activity. However, the redox potential of COA6 is unknown. To 
determine whether reduction of COX2 and SCO disulfides by COA6 is thermodynamically 
favorable, we measured the reduction potential of the ox/red COA6 couple using the 
DTTox:DTTred redox couple as a calibrant, and found that at −330 mV (pH 7.0) it is lower 
than that of SCO1 (−280 mV) and COX2 (−290 mV) (Figures 6A and 6B). The reduction 
potential of SCO2 has previously been shown to be < −300 mV (Banci et al., 2007). These 
reduction potential values suggest that both COA6 and SCO2 can reduce SCO1 and COX2 
in a thermodynamically favorable manner.
We then tested whether COA6 can effectively reduce the disulfide bonds of Cu-coordinating 
cysteines of its interacting partners. To do this, we used a thiol-alkylating reagent 4-
acetamido-4′-maleimidylstilbene-2,2′-disulfonic acid (AMS), which selectively reacts with 
free thiols on proteins to form a protein-AMS adduct. This modification increases the 
protein mass by ~ 0.5 kDa per free thiol. The additional mass leads to an upward shift on an 
SDS-PAGE gel (Figure 6C). Utilizing this assay, we observed that a 1-h co-incubation of 
reduced COA6 with either of the oxidized SCO proteins led to the appearance of two SCO-
specific bands in the AMS-treated samples (Figure 6D). This observation suggests that 
COA6 can reduce the disulfides of SCO proteins, generating free sulfhydryl groups that then 
react with AMS. Similarly, we found that COA6 can also reduce the cysteines of COX2 
(Figure 6E).
Finally, to corroborate these in vitro findings, we tested the redox state of the cysteinyl thiols 
of SCO proteins in vivo in COA6 patient fibroblasts using AMS and a second alkylating 
agent iodoacetamide (IAM). As shown previously, the cysteinyl sulfurs of SCO1 and SCO2 
proteins exist as a mixed redox population in control fibroblasts that is composed of both 
oxidized and reduced thiols (Figure 6F) (Leary et al., 2009). Strikingly, mutations in COA6 
significantly skew the relative ratio of reduced to oxidized cysteinyl sulfurs of SCO1, with 
the oxidized species predominating (Figure 6F). In contrast, the ratio of oxidized-to-reduced 
sulfur species of SCO2 was comparable in control and COA6 patient fibroblasts (Figure 6F). 
Taken together, these findings provide further evidence that COA6 acts as a disulfide 
reductase in vivo and suggest that SCO1 is one of its substrates.
To determine how the redox function of COA6 affects the synthesis and stability of COX2, 
we performed pulse-chase labeling of mitochondrial DNA-encoded proteins in control, 
COA6, SCO1, and SCO2 patient fibroblasts. Consistent with our previous studies, we found 
that COX2 is synthesized normally in SCO1–1 cells but is rapidly turned over during the 
chase (Cobine et al., 2006), while its synthesis is attenuated in SCO2 cells yet it accumulates 
during the chase (Leary et al., 2009) (Figure S5). The profile of COX2 synthesis and 
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degradation in COA6 patient fibroblasts most closely mirrors that observed for SCO2 cells 
(Figure S5), a result that would be expected if COA6 has a similar biochemical function to 
that of SCO2, which has previously been shown to have disulfide reductase activity (Leary 
et al., 2009; Morgada et al., 2015). Consistent with the idea that COA6 potentiates SCO1 
function and functionally overlaps with SCO2 to some degree, we found that overexpressing 
COA6 in SCO1 and SCO2 patient cell lines partially rescues CcO activity and COX2 levels 
(Figures S6A and S6B).
DISCUSSION
A large body of data has established that Cu insertion in the evolutionarily conserved 
binuclear CuA center of CcO occurs in the mitochondrial IMS (Baker et al., 2017; Timón-
Gómez et al., 2018). Catalyzing the necessary biochemical reactions in this sub-
mitochondrial compartment poses two challenges. First, the Cu-coordinating cysteines of 
COX2 must be re-reduced to the dithiol form if they become oxidized to disulfides in the 
oxidizing environment of the IMS. Second, the Cu metallochaperone responsible for 
delivering Cu to the CuA site must be present in the IMS with its Cu-coordinating thiols kept 
in the reduced state in order to bind Cu ions. Thus, CuA assembly is necessarily a two-step 
process that involves reducing the disulfides of newly synthesized apoCOX2 followed by Cu 
transfer from a metallochaperone. Here, we show that COA6 is a CHCH domain-containing 
protein that facilitates CuA site maturation by exhibiting disulfide reductase activity toward 
apo- COX2 and SCO1, the metallochaperone that delivers Cu to reduced apoCOX2. Thus, 
COA6 likely plays a dual role in CuA site maturation by maintaining the Cu-coordinating 
cysteines of COX2 and its metallochaperone SCO1 in the thiol/thiolate oxidation state to 
allow for Cu binding.
We have recently shown that metallation of the CuA site can be achieved in vitro by the 
combined action of SCO1 and SCO2 proteins, where SCO1 acts as a metallochaperone to 
transfer two Cu(I) equivalents to COX2 after SCO2 has reduced its cysteine residues to 
render it competent for Cu binding (Morgada et al., 2015). While the two orthologous SCO 
proteins thus are sufficient to form the CuA center in vitro, genetic and protein-protein 
interaction data all argue that the final step in the metallation of CuA site requires the 
combined activities of at least three proteins: SCO1, SCO2, and COA6 (Ghosh et al., 2016; 
Pacheu-Grau et al., 2015; Stroud et al., 2015). To address the discrepancy between the in 
vitro and in vivo data, we decided to focus on determining the function of COA6, the most 
recently discovered member of this Cu delivery pathway.
The fact that human COA6 is a small, soluble protein makes it highly amenable to NMR-
based structure determination. Thus, we utilized NMR to solve the solution structure of 
COA6 and identify a CHCH domain (Figure 1F). Consistent with our studies, Maghool et al. 
(2019) recently published the X-ray crystallographic structure of a COA6 dimer while we 
were revising our article, showing that each COA6 monomer has a CHCH fold with the first 
two helices being stabilized by disulfide bonds. The presence of COA6 as a dimer both in 
vitro (Figure 1C) and in vivo (Figures 5A and 5C) suggests that dimerization may be 
physiologically significant. Based on our observations that the COA6 dimer is readily 
disrupted in the presence of either SCO protein and binds to SCO proteins as a monomer 
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(Figure 3), we speculate that COA6 dimerization in vivo may prevent its non-specific 
activity against other mitochondrial intermembrane space proteins. The CHCH domain 
identified in COA6 has been proposed to be the minimal domain require for thiol-disulfide 
oxidoreductase activity (Banci et al., 2009a). We found that COA6 function can be bypassed 
under reducing or hypoxic conditions (Figures 5E–5G), suggesting that it may exhibit 
disulfide reductase activity. Indeed, our in vitro and in vivo experiments further support this 
notion and identified SCO1 and COX2 as COA6 client proteins (Figures 3 and 6). Having 
two client proteins for a disulfide reductase is not without precedent; the bacterial 
periplasmic protein thioredoxin TlpA acts as a specific reductant for both of the 
metallochaperones SCO1 and COXB, the bacterial equivalent of COX2 (Abicht et al., 2014; 
Mohorko et al., 2012). Thus, COA6 appears to be a functional homolog of bacterial TlpA; 
however, it likely represents a product of convergent evolution, as there is no sequence 
homology between the two proteins. We propose that the client-specific disulfide reductases 
in the bacterial periplasmic space and the mitochondrial IMS are required to counter the 
oxidizing environment of these compartments, which would prevent Cu coordination by 
promoting disulfide bond formation in the Cu-binding proteins (Herrmann et al., 2009).
Our findings beg the question why three proteins—COA6, SCO1, and SCO2—are needed in 
vivo when SCO1 and SCO2 are sufficient to form a CuA center in vitro. The redox states of 
SCO1 and SCO2 in vitro were set to favor Cu delivery to the CuA site (Morgada et al., 
2015). In vivo, however, the reduced states of these proteins must be continuously 
regenerated for the proteins to function. Thus, after delivering Cu to the CuA site, the 
cysteines of SCO1 are likely to be more prone to oxidation given the oxidizing nature of the 
mitochondrial IMS, necessitating their subsequent reduction to bind Cu for the next round of 
Cu delivery to apoCOX2. In this setting, COA6 function may be critical. Previously, it was 
shown that the metallochaperone COX17 is capable of transferring both reducing 
equivalents and Cu to SCO1 in vitro, although the redox potential of the S-S/2SH redox 
couple of COX17 (−198 mV) is not thermodynamically favored to reduce the disulfide of 
SCO1 (−277 mV) (Banci et al., 2008) but a Cu-bound COX17 is able to overcome 
unfavorable thermodynamic driving force in vitro. Based on these observations and our 
findings, it appears that COA6 is a more likely electron donor for SCO1 in vivo.
By combining both in vivo and in vitro approaches, our study demonstrates that the 
mechanism of mitochondrial CuA site biogenesis requires the combined activities of COA6, 
SCO1, and SCO2, with COA6 facilitating Cu delivery to the CuA site by keeping the Cu-
binding cysteines of SCO1 and COX2 in their reduced states (Figure 7). This model raises 
an obvious question regarding the ultimate source of the reducing power. Although at 
present this remains unknown, our model is consistent with the previously documented 
synthetic lethal interaction between coa6Δ and sco2Δ yeast mutants (Ghosh et al., 2016), in 
that both COA6 and SCO2 exhibit disulfide reductase activities with some overlapping 
substrate specificity in SCO1 and/ or COX2 (Figure 7). Our structural model of the 
COA6:SCO1 complex (Figure 4E) suggests a possible redox pathway for shuttling electrons 
from COA6 to the Cu-binding cysteines of SCO1 (Cys 169 and Cys173). Both Cys169 and 
Cys173 are in close proximity to the indole ring of W48 from COA6, which is also within 
5Å of the Cys12/Cys44 disulfide bridge of COA6. We propose that the polarizable π 
electrons of the W48 indole ring could help relay the transfer of electrons between Cys12/
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Cys44 (of COA6) and Cys169/Cys173 (of SCO1) as a possible mechanism of the observed 
COA6 disulfide reductase activity. We further suggest that the other COA6 disulfide bridge 
(Cys22/Cys33) may similarly help catalyze the reduction of disulfides in COX2. In this 
scenario, a ternary complex of COA6 bound to both SCO1 and COX2 could simultaneously 
promote Cu binding to both SCO1 and COX2. This model is supported by our previous 
study, which showed that a pathogenic mutation in the first tryptophan residue of COA6 
disrupts its ability to interact with COX2 but not with SCO1, indicating that COA6 uses 
distinct surfaces to interact with each protein (Ghosh et al., 2016). Additional support for our 
model comes from a recent report, which identified a SCO1-COA6-COX2 assembly module 
in yeast CcO biogenesis (Franco et al., 2018). In summary, our work provides structural, 
biochemical, and in vivo data supporting the role of COA6 as a disulfide reductase in the 
IMS and advances the mechanistic model of CuA site assembly within the complex picture 
of CcO biogenesis.
STAR✶METHODS
LEAD CONTACT AND MATERIALS AVAILABILITY
Further information and requests for resources and reagents should be directed to and will be 
fulfilled by the Lead Contact, Vishal M. Gohil (vgohil@tamu.edu). All unique/stable 
reagents generated in this study are available from the Lead Contact without restrictions.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Yeast Strains and Culture Conditions—All strains used in this study are listed in the 
Key Resources Table, and all the primers used in this study are listed in Table S2. Yeast cells 
were grown in YP (1% yeast extract, 2% bactopeptone) medium with 2% dextrose (YPD) or 
3% glycerol + 1% ethanol (YPGE) as carbon sources. Synthetic media was prepared with 
0.17% yeast nitrogen base, 0.5% ammonium sulfate, 0.2% dropout amino acid mix and 2% 
dextrose as a carbon source. Solid media was prepared by further adding 2% agar. Growth 
was measured spectrophotometrically at 600 nm in liquid medium or by spotting on solid 
plates. For hypoxic growth conditions on solid media, indicated plates were incubated in a 
hypoxia incubator chamber (STEMCELL Technologies) purged with a certified gas mixture 
(4% oxygen, 5% carbon dioxide and 91% nitrogen). For hypoxic growth conditions in liquid 
media, synthetic complete raffinose liquid media, which constitutes 2% raffinose and 1x 
TEM (0.5% Tween80, 2.4 μg/ml ergosterol, 55.6 μg/ml methionine), was kept in a glove box 
with nitrogen gas for 24 hr prior to culturing the indicated strains at 30°C while shaking at 
225 rpm.
Mammalian Cell Culture—Primary fibroblasts from control, COA6 (Baertling et al., 
2015), SCO1–1 (R149X/P174L; Valnot et al., 2000), SCO1–2 (V93X/M294V; Leary et al., 
2013) and SCO2–9 (Leary et al., 2013) were immortalized as described (Leary et al., 2004). 
Fibroblasts were transduced at 40%–60% confluency with retrovirus produced by the 
Phoenix amphotrophic packaging cell line, and selected in media containing hygromycin or 
puromycin to yield stable overexpression cell lines (Leary et al., 2004). Both fibroblasts and 
the packaging cells were grown in high-glucose DMEM containing 10% bovine growth 
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serum (ThermoFisher) at 37°C in 5% CO2 and were tested to ensure that they were 
Mycoplasma-free (Lonza MycoAlert) before harvesting.
METHOD DETAILS
Cloning and Expression—E.coli codon optimized human COA6 isoform3 was cloned 
into the pGEX4t-1 vector using BamHI and XhoI restriction endonucleases to generate N-
terminal, GST-fused COA6. E.coli codon optimized yeast COA6 was cloned into the 
pET28a plasmid using XhoI and EcoRI restriction endonucleases to generate N-terminal, 
His-GFP-fused COA6. The resultant plasmids were then transformed into E.coli BL 
21(DE3) cells. Human COA6 and yeast Coa6 expression was induced by the addition of 0.5 
mM isopropyl-D-thiogalactopyranoside (IPTG) at an optical density of 600 nm (OD600) of 
0.6, and the cells were grown at 37°C and 16°C for 4 hr and 12 hr respectively. 15N/13C 
labeled proteins for NMR structural characterization were expressed in cells grown in 
minimal medium, which contained 3 g/liter KH2PO4, 6.8 g/liter Na2HPO4, 0.1 mM CaCl2, 2 
mM MgCl2, 1x Basal Medium Eagle (BME) vitamin solution (Sigma), 1 g/liter 15N-
ammonium chloride and 4 g/liter 13C-D-glucose (Sigma).
Protein Purification—To purify human COA6, cells were resuspended in lysis buffer (50 
mM Tris [pH 7.4], 150 mM NaCl, 1 mM PMSF and 0.1% Triton X-100) and lysed by 
repeated sonication on ice for a total of 4 min. The lysate was clarified by centrifugation at 
40,000 g for 30 min at 4°C and the supernatant was applied to a GST binding column pre-
equilibrated with a buffer containing 50 mM Tris (pH 7.4) and 150 mM NaCl. GST-COA6 
was eluted in equilibration buffer supplemented with 10 mM reduced glutathione. Eluted 
GST-COA6 was subjected to thrombin digestion (20 units of thrombin for 100 mg of GST-
COA6 protein) for 12 hr at room temperature. COA6 from the flow-through was then 
injected into a HiPrep Sephacryl S-100 column pre-equilibrated with a 20 mM Tris (pH 7.4) 
and 150 mM NaCl solution.
To purify yeast Coa6, cells were resuspended in lysis buffer containing 20 mM Tris (pH 8), 
500 mM NaCl, 1 mM PMSF and 6 mM imidazole and sonicated on ice for 4 min. The lysate 
was clarified by centrifugation at 40,000 g for 30 min at 4°C and the supernatant was 
applied to a HisTrap HP column pre-equilibrated with 20 mM Tris (pH 8), 500 mM NaCl, 
and 6mM imidazole. His-GFP-Coa6 was eluted using 20 mM Tris (pH 8), 500 mM NaCl, 
and 400 mM imidazole. Eluted His-GFP-Coa6 was subjected to TEV digestion for 12 hr at 
4°C. Yeast Coa6 was further purified using a Superdex 200 column pre-equilibrated with 
20mM Tris (pH 7.4) and 500 mM NaCl. Human SCO1 and SCO2 were purified as described 
(Banci et al., 2006, 2007).
NMR Spectroscopy—NMR data were acquired in Shigemi tubes on 0.015 – 0.947 mM 
COA6 samples buffered in 20mM Tris (pH 7.4), 150 mM NaCl and 10% (v/v) D2O. All 
NMR experiments used for the structure calculation were carried out at 25°C on the Bruker 
Avance 800 MHz, 600 MHz, or 500 MHz NMR spectrometers equipped with a 5 mm triple-
resonance cryoprobe and single-axis pulsed field gradient by using standard pulse programs 
provided by the instrument manufacturer. NMR data were acquired and processed by using 
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the software Topspin, version 3.2 (Bruker, Germany), and were further analyzed in Sparky, 
version 3.112 (University of California, San Francisco).
1H, 13C, and 15N resonance assignments for Coa6 were indirectly referenced according to 
the IUPAC recommendations (Markley et al., 1998). The protein backbone resonance 
assignments were achieved through analysis of the 3D-triple resonance experiments and the 
aliphatic side-chain resonances were primarily assigned using 3D-HCCH-COSY and 15N-
edited TOCSY-HSQC acquired with 60 ms mixing time. Aromatic side-chains were 
assigned using 2D-homo-nuclear TOCSY and NOESY spectra and verified with 2D-
experiments 13C-HMQC and (HB)CB(CGCD)HD. NOE distance restraints were based on 
3D-experiments, 13C-edited NOESYHSQC and 15N-edited NOESY HSQC, each acquired 
with a 150 ms mixing time. Semi-automated NOE cross-peaks were assigned using the 
CYANA software package (Güntert and Buchner, 2015) and were manually checked for 
correctness in an iterative manner. Dihedral angle restraints were predicted from the 
backbone chemical shifts using the program TALOS+ (Shen et al., 2009). Sixteen slowly 
exchanging backbone amide protons identified in the H/D exchange experiments were 
predicted to belong in a-helical regions by the chemical shift index analysis (Wishart and 
Sykes, 1994) and the NOESY patterns. Thus 32 corresponding distance restraints for HN-O 
and N-O atoms were imposed in the final structure calculation to depict the H-bonds 
(Williamson et al., 1985). Isotope-filtered NOESY experiments (3D-13C,15N-filtered/edited 
NOESY HSQC) were performed on a sample prepared by mixing a 1:1 ratio of unlabeled 
and 13C,15N-labeled sample to identify inter-subunit contacts between COA6 dimer. These 
experiments failed to reveal any cross peaks due to the weak dimerization constant and thus 
were not used in further analysis.
COA6 subunit structure calculation was performed using CYANA, version 3.96, following a 
torsion angle molecular dynamics protocol (Güntert et al., 1997). Two hundred random 
conformers were annealed in 15,000 steps for 7 cycles, and 20 structures with the lowest 
target functions after the final cycle were selected for water refinement, which was 
performed using the software X-plor NIH version, 2.50 (Schwieters et al., 2003). The 
structure ensemble was validated with the Protein Structure Validation Software suite 1.5 
(Bhattacharya et al., 2007).
Relaxation Measurements—15N relaxation experiments were performed on 15N-labeled 
COA6 samples at 25°C on the 600 MHz spectrometer. Ten 15N longitudinal relaxation rate 
constant (R1) experiments were performed in random order, with relaxation delays of 10 
(duplicate), 90, 190, 320, 470 (duplicate), 660, 936, 1500 ms. Similarly, the transverse 
relaxation rate constant (R2) experiments were performed with relaxation delays of 0 
(duplicate), 16.9, 33.9, 50.9 (duplicate), 67.8, 84.8, 118.7, 186.6 ms. Both rate constants 
were calculated using the program Curvefit, assuming a monoexponential decay of the peak 
intensities. The errors in the peak intensities were calculated from the two duplicate 
experiments. The steady-state heteronuclear [1H]-15N NOE experiment was carried out in an 
interleaved manner, with and without proton saturation and repeated thrice. The NOE effect 
was calculated as an average ratio of the peak intensities.
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Online Liquid Chromatography-Inductively Coupled Plasma-Mass 
Spectrometry (LC-ICP-MS)—Cu binding to purified COA6 and COA6 within yeast 
mitochondrial extracts was measured using an online LC-ICP-MS system. A bioinert HPLC 
system (Agilent Technologies, 1260) located inside a chilled and refrigerated glove box 
(MBraun, labmaster 130) was connected to an ICP-MS (Agilent Technologies, 7700x) via 
PEEK tubing coming from the diode array of the LC system in the glove box. The HPLC 
system was composed of a pump (G5611A), diode array (G4212B), fraction collector 
(G5664A) and manual injector. The ICP-MS was interfaced with the LC system via a 
micromist nebulizer attached to a Scott-type spray chamber. The ICP-MS was tuned daily 
prior to analyzing samples. Samples were analyzed in helium collision mode. The 
instrument was tuned as described (Dziuba et al., 2018).
Samples were analyzed either with two Superdex Peptide 10/300 GL (GEHealthcare) 
columns connected in series or with a Bio SEC-3 (Agilent Technologies) column. Samples 
were passed through either a Titan regenerated cellulose 0.2 mm filter (Thermo scientific) or 
a 0.2 mm cellulose acetate filter (VWR). The dual peptide columns used a mobile phase of 
20 mM Tris (pH 7.4) and 10 mM NaCl at a flow rate of 0.350 mL/min for a total of 160 min 
per run and a loop volume of 300 μL. The Bio SEC-3 column used a mobile phase of 20 mM 
Tris (pH 7.4) and 150 mM NaCl at a flow rate of 0.4 mL/min for a total of 10 min per run 
and a loop of 20 μL. The diode array was set for detection and data collection at 280 nm. 
Molecular mass standards were cyanocobalamin (1.3 kDa) from Fisher BioReagents and 
cytochrome c (12 kDa), carbonic anhydrase (30 kDa), albumin (66 kDa) and apoferritin (443 
kDa) all from Sigma.
Gel-Filtration Chromatography—The apparent molecular mass of COA6 was 
determined using gel filtration chromatography. COA6 (100 μM) was loaded onto a 
Superdex 75 10/300 GL column equilibrated with 20 mM Tris (pH 7.4) and 150 mM NaCl 
at a flow rate of 0.3 ml/min. Aprotinin (6.5 kDa), cytochrome c (12.4 kDa), carbonic 
anhydrase (29 kDa) and albumin (66 kDa) were used as molecular weight references 
(Sigma, MWGF70).
Haddock Docking Calculation of the COA6:SCO1 Complex—The molecular 
docking of COA6 and SCO1 was performed using the Haddock d-level 2.2 web server as 
described (van Zundert and Bonvin, 2014). Chemical shift perturbation data were used as 
structural restraints (referred to as ambiguous interaction restraints (AIR)). The docking 
calculation used the NMR structure of COA6 determined in this study and the crystal 
structure of SCO1 (PDB: 2GVP) as input structures for the docking calculation. A total of 
26 AIR restraints were used based on chemical shift perturbation data for COA6 (Figure 4A) 
and SCO1 (Figure 4C). Initial docking calculations generated 200 structures (with the lowest 
energy) that were then used for subsequent simulated annealing and water refinement. The 
final docked structures (10 lowest energy structures) had an overall RMSD of 1.8Å.
SDS-PAGE and Western Blotting—Yeast mitochondrial proteins (20 μg) were 
separated by SDS-PAGE and blotted onto a polyvinylidene difluoride membrane. 
Membranes were treated for 1 hr in blocking buffer containing 5% nonfat milk dissolved in 
Tris-buffered saline with 0.1% Tween 20 (TBST-milk), followed by overnight incubation 
Soma et al. Page 15
Cell Rep. Author manuscript; available in PMC 2020 January 07.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
with primary antibody in TBST-milk at 4°C. Primary antibodies were used at the following 
dilutions: Cox2, 1:100,000 (Abcam 110271); Coa6, 1:5000 and Porin, 1:50,000 (Abcam 
110326).
For the experiments with human cell lines, whole cells were homogenized on ice in STE 
buffer (250 mM sucrose, 10 mM Tris-HCl, pH 7.4, and 1 mM EDTA) supplemented with a 1 
× cOmplete protease inhibitor cocktail (Roche, Indianapolis, IN) and 0.5 mM 
phenylmethylsulfonyl fluoride (PMSF; Sigma-Aldrich) and centrifuged twice at 4°C for 10 
min at 600 × g to obtain a postnuclear supernatant. A crude mitochondrial fraction was then 
obtained by centrifugation at 4°C for 10 min at 8000 × g and used for non-reducing SDS– 
PAGE analyses as described (Leary and Sasarman, 2009). Alternatively, whole cells were 
extracted in a RIPA extraction buffer (50 mM Tris (pH 7.4), 150 mM NaCl, 1% Triton 
X-100, 0.5% sodium deoxycholate, 0.1% SDS, 1 mM EDTA and 1x Complete protease 
inhibitor cocktail), adjusted to a final concentration of 5 mg/ml, incubated on ice for 30 min 
and then centrifuged at 4 °C for 10 min at 14 000 × g and used for reducing SDS-PAGE 
analyses (Boulet et al., 2018).
For both reducing and nonreducing SDS–PAGE gels, equal amounts of protein were 
separated on precast gels (BioRad), transferred to nitrocellulose membrane, blocked for 2 hr 
in Tris buffered saline supplemented with 0.05% Tween 20 (TBST; 25 mM Tris (pH 7.4), 
137 mM NaCl, 2.5 mM KCl and 0.05% Tween 20) containing 5% milk, and incubated 
overnight at 4 °C in primary antibody. Membranes were then washed six times for 5 min in 
TBST, incubated for 60 min in the appropriate horseradish peroxidase conjugated secondary 
antibody (BioRad, 1: 2500) in TBST containing 5% milk, and washed again in TBST as 
above. Primary antibodies were used at the following dilutions: SCO1, 1:1000 (Bourens et 
al., 2014); SCO2, 1:1000 (Fitzgerald 70R-20118); COA6, 1:1000 (Proteintech 24209–1-
AP); COX2, 1:1000 (Mitoscience MS405); GAPDH, 1:1000 (Cell signaling 14C10–2118) 
and Actin, 1:5000 (Bio-Rad 12004163). Membranes were developed using a homemade 
luminol-enhanced chemiluminescence solution, and visualized with the BioRad ChemiDoc 
MP Imaging System.
CcO Activity—Cco activity was measured as described (Capaldi et al., 1995). Briefly, we 
used triethanolamine/EDTA buffer to make a cell suspension, which is then added to a 96-
well plate and the oxidation rate of cytochrome c was measured at 550nm. The activity assay 
was performed in potassium phosphate buffer (50mM pH 7) that contained cytochrome c 
and the mild detergent dodecylmaltoside.
Redox State Determination—The in vitro redox state of the cysteine residues in protein 
and protein mixtures were investigated by nonreducing SDS-PAGE after reaction of the 
samples with and without AMS as described previously (Morgada et al., 2015). Reduced and 
oxidized samples and protein mixtures (20–40 μM) were treated in an anaerobic 
environment with 1% (wt/vol) SDS and 10 mM AMS for 1 hr at 37°C, and resolved on 17% 
SDS-PAGE gels under nonreducing conditions.
Reduction Potential Determination—The midpoint reduction potential of the cysteine 
residues of COA6 was estimated by monitoring the redox state of thiols in COA6, using 
Soma et al. Page 16
Cell Rep. Author manuscript; available in PMC 2020 January 07.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
AMS and non-reducing SDS-PAGE after incubation in redox buffers. Samples of fully 
oxidized Coa6 (25 mM) were incubated for 24 hr in 50 mM phosphate pH 7 buffer with 
different ratios of oxidized and reduced DTT. Reduced DTT and Oxidized DTT solutions 
were prepared by dissolving the solid form of each (sigma Aldrich D0632 and D3511 
respectively) in 50 mM nitrogen-fluxed potassium phosphate buffer (pH 7) under anaerobic 
conditions. The redox potential of the buffers (EBuff) was estimated using the Nernst 
equation: EBuff = E0 + 29.4log ([DTTox]/[DTT]2) with E0 being −332 mV for the DTT 
redox couple at pH 7.0 using with a 1 mM being the maximal concentration of reduced DTT. 
After incubation, reactions were quenched by addition of 5 mM AMS (Thermo Fisher 
A485), 2% SDS and incubated at 37°C for 1 hr. Non-reducing protein loading buffer was 
added to the samples and the redox state of the proteins was followed by SDS-Gel shift 
assay in 16% polyacrylamide gel. The reduced fractions were quantified using the ImageJ 
software.
In Vitro Labeling of Mitochondrial Translation Products—Cells were labeled in 6 
cm dishes as described in detail elsewhere (Leary and Sasarman, 2009). Briefly, cells were 
incubated in chloramphenicol (Sigma) prior to labeling to inhibit mitochondrial translation 
and allow for the accumulation of nuclear-encoded respiratory chain subunits. 400 mCi of a 
[35S]-methionine and cysteine mixture (Easy Tag EXPRESS) was added for 60 min to cells 
in methionine- and cysteine-free DMEM containing 10% dialyzed fetal bovine serum 
(GIBCO) and anisomycin (Sigma), to reversibly inhibit cytoplasmic translation. Total 
cellular protein (50 mg) was resuspended in sample loading buffer containing β-
mercaptoethanol, sonicated and run on a 12%–20% gradient gel. Gels were subsequently 
transferred to nitrocellulose under semi-dry conditions and the [35S]-labeled mitochondrial 
translation products were detected through digital autoradiography.
QUANTIFICATION AND STATISTICAL ANALYSIS
Data are shown as mean ± standard deviation (SD) or mean ± standard error of the mean 
(SEM), and the number of replicates is indicated in the figure legends. Values of p < 0.05 
were considered significant. Statistical analysis was performed using GraphPad Prism 
version 8 (GraphPad Software, La Jolla California USA, https://www.graphpad.com).
DATA AND CODE AVAILABILITY
The solution structure of human COA6 isoform 3 has been deposited in the Protein Data 
Bank with the accession code PDB: 6NL3.
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Refer to Web version on PubMed Central for supplementary material.
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Highlights
• COA6 is a coiled-coil-helix-coiled-coil-helix domain containing protein
• COA6 preferentially interacts with SCO1 over SCO2
• COA6 acts as a disulfide reductase of SCO1 and COX2
• COA6 function can be bypassed under hypoxic conditions
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Figure 1. Solution Structure of Human COA6
(A) Primary structure of human COA6. No NMR assignments were achieved for the 
residues colored in red.
(B) SDS-PAGE analysis of the samples obtained during COA6 purification steps: lane 1, 
supernatant of lysate from E. coli expressing the COA6-GST fusion protein; lane 2, eluate 
containing COA6-GST from the GST binding column; lane 3, COA6-GST after cleaving the 
GST tag with thrombin; and lane 4, purified COA6 sample from gel filtration 
chromatography.
(C) Elution profile of purified COA6 from the Superdex 75 gel-filtration column.
(D) 1H-15N HSQC spectrum of human COA6.
(E) Ensemble of the 20 NMR solution structures of COA6 by backbone representation.
(F) Ribbon representation of human COA6 based on the lowest energy conformer of 
solution structures. Human COA6 has four helixes labeled as H1, H2, H3, and H4, and the 
two disulfide bonds between H1 and H2 are shown in yellow.
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Figure 2. Mapping COA6 Patient Mutations onto the COA6 Structure
(A) Sequence alignment of the conserved region of COA6 across indicated model 
organisms. Horizontal lines above Cx9C and Cx10C residues show the conserved 
Cx9CxnCx10C motif. Schematic representation of the yeast-human hybrid COA6 (hyCOA6) 
protein, where the sequences from yeast Coa6 and human COA6 are shown in cyan and 
blue, respectively. Arrows indicate amino acid residues that were mutated in human COA6 
patients and the corresponding residues in the hyCOA6 protein.
(B) Ribbon representation of COA6 patient mutations mapped onto the COA6 structure in 
red.
(C) Wild-type (WT) and coa6Δ cells transformed with empty vector (EV) or vector-
expressing hyCOA6 or hyCOA6 harboring patient mutations (W26C, W33R, and E54X) 
were serially diluted and seeded on YP glycerol-ethanol (YPGE) plates. Cells were grown at 
30°C and 37°C for 5 days.
(D and E) SDS-PAGE/western blot analysis of whole cell (D) and mitochondrial protein (E) 
extracts from coa6Δ cells expressing wild-type or mutant hyCOA6 proteins. Por1 and Pgk1 
were used as loading controls.
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(F) Human control and COA6 patient cell lines were transduced with cDNAs expressing 
either WT or pathogenic variants of COA6 followed by measurement of CcO activity. Data 
are represented as mean ± SEM, n = 3.
(G) SDS-PAGE/western blot depicting COA6, COX2, and GAPDH (loading control) levels 
in protein lysate from control and COA6 cell lines as indicated in (D). The data shown are 
representative of at least three independent replicates.
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Figure 3. Human COA6 Exhibits a Stronger Interaction with SCO1 than SCO2
(A–C) Size exclusion chromatography elution profiles of (A) COA6, (B) SCO1, and (C) 
SCO2.
(D–H) Elution profiles of the indicated mixtures of proteins (solid lines), compared to 
simulations of the indicated individual proteins or mixtures of two or more proteins (dotted 
lines).
(I) SDS-PAGE/western blot analysis of different fractions from size exclusion 
chromatogram shown as the solid black line in (F)–(H).
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Figure 4. Mapping the Surfaces That Mediate Interactions between COA6 and SCO1
(A) Average chemical shift perturbation of 15N-labeled COA6 upon addition of equimolar 
unlabeled SCO1. Horizontal solid line, mean chemical shift perturbation; dashed line, mean 
+ SD of chemical shift perturbation for all residues; solid circles, unassigned residues; and 
open circles, residues with broadened peaks upon complex formation.
(B) COA6 residues with significant chemical shift perturbations are colored in red on a 
ribbon representation of COA6.
(C) Chemical shift perturbation of 15N-labeled SCO1 residues upon addition of equimolar 
unlabeled COA6, as displayed in (A).
(D) SCO1 residues with significant chemical shift perturbations are colored in red on a 
ribbon representation of SCO1.
(E) A HADDOCK docking model of the COA6:SCO1 complex generated using chemical 
shift perturbation (CSP) data. The side chain of the COA6 tryptophan (W48) and the 
indicated cysteine residues of COA6 and SCO1 are shown in stick representations in red.
(F) WT and coa6Δ cells transformed with empty vector (EV) or vector expressing either 
full-length or truncated hyCOA6. Transformants were serially diluted on agar plates and 
grown for 5 days.
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(G) SDS-PAGE/western blot analysis of protein extracts from coa6Δ cells expressing wild-
type or truncated mutants of hyCOA6. Pgk1 was used as loading control.
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Figure 5. A Reducing Environment Rescues the Respiratory Growth of coa6Δ Cells
(A and B) Cu traces from online LC-ICP-MS of solubilized mitochondrial extracts from WT 
(A) or coa6Δ (B) cells. The dotted lines indicate simulated curves generated by peak fitting.
(C and D) SDS-PAGE/western blot depicting Cox2 and Coa6 protein levels in the different 
LC-ICP-MS fractions of WT (C) and coa6Δ (D) soluble mitochondrial extracts.
(E) Serially diluted WT, coa6Δ, sco1Δ, sco2Δ, cox17Δ, cox11Δ, and coa6Δsco2Δ cells were 
spotted on YP dextrose (YPD) and YP glycerol-ethanol (YPGE) plates and grown under 
normoxic or hypoxic (4% O2) conditions.
(F) Western blot of Cox2 in the indicated yeast strains. Por1 was used as a loading control.
(G) WT and coa6Δ cells were cultured in YPGE medium at 37°C in the presence or absence 
of reduced glutathione (GSH) at the indicated concentrations. The cell density was measured 
spectrophotometrically at the indicated time points. These data are representative of at least 
three independent replicates.
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Figure 6. COA6 Acts as a Thiol-Disulfide Reductase of SCO and COX2 Proteins
(A) Determination of the redox potential of recombinant human COA6 by subjecting it to 
increasing dithiothreitol (DTT) concentrations followed by treatment with the alkylating 
agent AMS to irreversibly modify cysteines containing reduced thiols. Oxidized and reduced 
species of COA6 were resolved by non-reducing SDS-PAGE.
(B) Schematic representation of the redox potential of COA6 relative to the previously 
determined redox potentials of COX2, SCO1, and the mitochondrial inter-membrane space 
(IMS).
(C) A schematic of how AMS reacts with reduced protein thiols resulting in protein-AMS 
adducts of increased mass and with retarded migration in SDS-PAGE gels under non-
reducing conditions.
(D and E) Migration patterns of purified recombinant human COA6, SCO1, and SCO2 (D) 
and COX2 (E) proteins with and without AMS treatment on non-reducing SDS-PAGE. 1-h 
co-incubation of reduced COA6 with oxidized SCO1, SCO2, or COX2 was followed by 
AMS treatment and SDS-PAGE. SCO and COA6 proteins were used at 1:1 and 1:2 
stoichiometries. COX2 and COA6 proteins were used at a 1:1 stoichiometry.
(F) Isolated human mitochondria from control (control 1 and control 2) and COA6 patient 
fibroblasts were incubated in the presence or absence of the reductant dithiothreitol (DTT), 
followed by treatment with the alkylating agents iodoacetamide (IAM) or AMS to 
irreversibly modify cysteines containing reduced thiols. Species of SCO1 and SCO2 
containing oxidized (ox) cysteines were then resolved from those with reduced (red) 
cysteines by non-reducing SDS-PAGE and detected by immunoblotting with the indicated 
antibodies. Red* refers to reduced thiols that were modified in the presence of AMS. These 
data are representative of three independent replicates.
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Figure 7. A Proposed Model of CuA Site Biogenesis
CuA site formation on the Cox2 subunit of CcO involves sequential transfer of Cu from 
Cox17 to Sco1 to Cox2. This process occurs in the mitochondrial inter-membrane space, an 
oxidizing environment that would promote the formation of disulfide bonds in the Cu-
coordinating cysteines of apo-Cox2 and apo-Sco1 proteins and prevent Cu binding. The 
thioldisulfide oxidoreductase activities of Coa6 and Sco2 overcome this problem by 
reducing the disulfides of apo-Cox2 and apo-Sco1 to dithiols, thereby allowing for Cu 
binding. Previous studies and the work described here suggest that Coa6 has dual substrates 
in Sco1 and Cox2 and that it exhibits overlapping substrate specificity with Sco2.
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KEY RESOURCES TABLE
REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Mouse monoclonal anti-Por11 Abcam Cat# ab110326; RRID:AB_10865182
Mouse monoclonal anti-Cox2 Abcam Cat# ab110271; RRID:AB_10858117
Rabbit polyclonal anti-Coa6 Gohil Lab N/A
Rabbit polyclonal anti- SCO1 Bourens et al., 2014 N/A
Rabbit polyclonal anti- SCO2 Fitzgerald Cat# 70R-20118
Rabbit Polyclonal anti- COA6 Proteintech Cat# 24209–1-AP
Mouse monoclonal anti- COX2 Mitoscience Cat# MS405; RRID:AB_1618186
Rabbit monoclonal anti- GAPDH Cell signaling Cat# 14C10–2118
hFAB Rhodamine anti-Actin Bio-Rad Cat# 12004163
Bacterial and Virus Strains
E. coli strain DH5α NEB Cat# C2987I
E. coli BL21(DE3) NEB Cat# C2527I
Chemicals, Peptides, and Recombinant Proteins
Ammonium-15N chloride Sigma-Aldrich Cat# 299251
BME Vitamins 100x solution Sigma-Aldrich Cat# B6891
D-(+)-Raffinose pentahydrate Sigma-Aldrich Cat# R0250
D-Glucose-13C6 Sigma-Aldrich Cat# 389374
DL-Dithiothreitol Sigma-Aldrich Cat# D0632
Ergosterol Sigma-Aldrich Cat# 45480
Isopropyl β-D-thiogalactoside Sigma-Aldrich Cat# I6758
Trans-4,5-Dihydroxy-1,2-dithiane (Oxidized DTT) Sigma-Aldrich Cat# D3511
Deposited Data
Human COA6 structure This Paper PDB: 6NL3
Experimental Models: Cell Lines
COA6 patient cell line Baertling et al., 2015 N/A
SCO1–1 (R149X/P174L) patient cell line Valnot et al., 2000 N/A
SCO1–2 (V93X/M294V) patient cell line Leary et al., 2013 N/A
SCO2–9 patient cell line Leary et al., 2013 N/A
Experimental Models: Organisms/Strains
S. cerevisiae: Strain background: BY4741 WT - MATa, 
his3Δ1, leu2Δ0, met15Δ0, ura3Δ0
Miriam L. Greenberg N/A
S. cerevisiae: Strain background: BY4741 coa6Δ - MATa, 
his3Δ1, leu2Δ0, met15Δ0, ura3Δ0 coa6Δ::kanMX4
Open Biosystems N/A
S. cerevisiae: Strain background: BY4741 sco1Δ - MATa, 
his3Δ1, leu2Δ0, met15Δ0, ura3Δ0 sco1Δ::kanMX4
Open Biosystems N/A
S. cerevisiae: Strain background: BY4741 sco2Δ - MATa, 
his3Δ1, leu2Δ0, met15Δ0, ura3Δ0 sco2Δ::kanMX4
Open Biosystems N/A
S. cerevisiae: Strain background: BY4741 cox11Δ - MATa, 
his3Δ1, leu2Δ0, met15Δ0, ura3Δ0 cox11Δ::kanMX4
Open Biosystems N/A
S. cerevisiae: Strain background: BY4741 cox17Δ - MATa, 
his3Δ1, leu2Δ0, met15Δ0, ura3Δ0 cox17Δ::kanMX4
Open Biosystems N/A
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REAGENT or RESOURCE SOURCE IDENTIFIER
S. cerevisiae: Strain background: STY10 sco2Δcoa6Δ - 
MATa, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, sco2Δ::KanMX4, 
coa6Δ::NatMX4
Ghosh et al., 2016 N/A
Recombinant DNA
pGEX4t-1- COA6 isoform3 This paper N/A
pET28a- Coa6 This paper N/A
pETG-30A- SCO1 Banci et al., 2006 N/A
pETG-30A- SCO2 Banci et al., 2007 N/A
pET9a-COX2-chimeric protein Morgada et al., 2015 N/A
pRS416 -hyCOA6 Ghosh et al., 2016 N/A
pRS416 -hyCOA6w26C Soma et al., 2018 N/A
pRS416 -hyCOA6w33R Soma et al., 2018 N/A
pRS416 -hyCOA6E54X Soma et al., 2018 N/A
pRS416 -hyCOA6(Δ65–79) This paper N/A
pRS416 -hyCOA6(Δ73–79) This paper N/A
Software and Algorithms
The PyMOL Molecular Graphics System, v2.0 Schrödinger LLC https://pymol.org/2/
HADDOCK2.2 van Zundert and Bonvin, 2014 http://haddock.science.uu.nl/services/
HADDOCK2.2/
Topspin, version 3.2 Bruker, Germany N/A
Sparky, version 3.112 UCSF https://www.cgl.ucsf.edu/home/sparky/
distrib-3.112/download.html
CYANA software package Güntert and Buchner, 2015 https://www.las.jp/english/products/
cyana.html
TALOS+ Shen et al., 2009 https://spin.niddk.nih.gov/bax/nmrserver/
talos/
Xplor NIH version 2.50 Schwieters et al., 2003 https://nmr.cit.nih.gov/xplor-nih/
Protein Structure Validation Software suite 1.5 Bhattacharya et al., 2007 https://psvs-1_5-dev.nesg.org/
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